Literature DB >> 7217515

A multicenter study of ICU drug utilization.

M L Farina, A Levati, G Tognoni.   

Abstract

As part of a view of hospital practice a sample of medical records of 15 intensive care units were analysed for the following items: reason for and origin of admission, age, sex, full pharmacological history, length of stay, clinical outcome, discharge diagnosis. Antibiotic therapy, steroid use for shock, problems of hemostasis, and cardiovascular drugs are areas where an active intervention appears to be specifically needed. Interhospital differences in diagnostic and general care criteria, documentation of inappropriate therapeutic practice, lack of reliable data registration gave occasion for an extensive discussion with clinicians leading to decisions on exclusion of drugs from hospital formularies, organization of information programs and of controlled clinical trials. The application of simple techniques of drug utilization review has proved a useful, inexpensive tool for creating favourable conditions for wide scale improvement of therapeutic practice.

Entities:  

Mesh:

Year:  1981        PMID: 7217515     DOI: 10.1007/bf01738615

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  6 in total

1.  Should corticosteroids be given in shock?

Authors: 
Journal:  Drug Ther Bull       Date:  1976-02-13

2.  Drug utilization in a newborn intensive care unit.

Authors:  J V Aranda; S Cohen; A H Neims
Journal:  J Pediatr       Date:  1976-08       Impact factor: 4.406

3.  A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitis.

Authors:  C W Imrie; I S Benjamin; J C Ferguson; A J McKay; I Mackenzie; J O'Neill; L H Blumgart
Journal:  Br J Surg       Date:  1978-05       Impact factor: 6.939

4.  Death from acute pancreatitis. M.R.C. multicentre trial of glucagon and aprotinin.

Authors: 
Journal:  Lancet       Date:  1977-09-24       Impact factor: 79.321

5.  Absorption of oral and intramuscular chlordiazepoxide.

Authors:  D J Greenblatt; R I Shader; S M MacLeod; E M Sellers; K Franke; H G Giles
Journal:  Eur J Clin Pharmacol       Date:  1978-06-19       Impact factor: 2.953

6.  Drug utilization in a general intensive care unit.

Authors:  N Buchanan; R D Cane
Journal:  Intensive Care Med       Date:  1978-04       Impact factor: 17.440

  6 in total
  7 in total

1.  Withdrawal following sufentanil/propofol and sufentanil/midazolam. Sedation in surgical ICU patients: correlation with central nervous parameters and endogenous opioids.

Authors:  Maria Korak-Leiter; Rudolf Likar; Michael Oher; Ernst Trampitsch; Gerda Ziervogel; Joseph V Levy; Enno C Freye
Journal:  Intensive Care Med       Date:  2005-02-16       Impact factor: 17.440

2.  Pharmacokinetics of midazolam during continuous infusion in critically ill neonates.

Authors:  E Jacqz-Aigrain; P Daoud; P Burtin; S Maherzi; F Beaufils
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

3.  Sedation in the ICU.

Authors:  H R Vinik; I Kissin
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

Review 4.  Pharmacology of drugs frequently used in ICUs: midazolam and flumazenil.

Authors:  R Amrein; W Hetzel
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

5.  Pharmacokinetics of midazolam in critically ill neonates.

Authors:  E Jacqz-Aigrain; C Wood; I Robieux
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

6.  Pharmacotherapy in pediatric critical illness: a prospective observational study.

Authors:  Conor McDonnell; Stanley Hum; Helena Frndova; Christopher S Parshuram
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

Review 7.  Clinical pharmacological and therapeutic considerations in general intensive care. A review.

Authors:  M L Farina; M Bonati; G Iapichino; A Pesenti; F Procaccio; L Boselli; M Langer; A Graziina; G Tognoni
Journal:  Drugs       Date:  1987-12       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.